Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT02354118
Eligibility Criteria:
Inclusion Criteria:
* Able to read and understand English
* Has an implanted port in place less than one (1) year
* Evidence of a patent (unobstructed) port catheter prior to enrollment in the study
* Is receiving active treatment (i.e., receiving a therapeutic drug through the implanted port)
* Current treatment protocol projected to continue for a minimum of three (3) months
* Anticipates receiving care at the identified centers for 12 months following enrollment in the study
* Does not receive care of implanted port at any other facility
Exclusion Criteria:
* Has documented heparin platelet antibody (i.e., could not be randomized to either group) or other allergy to heparin
* Receiving therapeutic dose of an anticoagulant (e.g.,warfarin, heparin, enoxaparin)
* Does not have a BioFlo port (heparinized port)
* Does not meet one or more of the inclusion criteria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02354118
Study Brief:
Protocol Section:
NCT02354118